| Author | Title | Source | Year |
| Wei-Chin Hung, Teng-Hung Yu, Cheng-Ching Wu, Thung-Lip Lee, Wei-Hua Tang, Chia-Chi Chen, I-Cheng Lu, Fu-Mei Chung, Yau-Jiunn Lee, Chia-Chang Hsu. | Nonalcoholic Fatty Liver Disease Is Related to Abnormal Corrected QT Interval and Left Ventricular Hypertrophy in Chinese Male Steelworkers. | Int J Environ Res Public Health. 2022 Nov 6;19(21):14555. doi: 10.3390/ijerph192114555. | 2022 |
| Cai BH, Hsu YC, Yeh FY, Lin YR, Lu RY, Yu SJ, Shaw JF, Wu MH, Tsai YZ, Lin YC, Bai ZY, Shih YC, Hsu YC, Liao RY, Kuo WH, Hsu CT, Lien CF, Chen CC. | P63 and P73 Activation in Cancers with p53 Mutation. | Biomedicines. 2022 Jun 23;10(7):1490. doi: 10.3390/biomedicines10071490. | 2022 |
| Ching-Ting Wei, Yu-Wen Wang, Yu-Chiuan Wu, Li-Wei Lin, Chia-Chi Chen, Chun-Yin Chen, Shyh-Ming Kuo. | Reparative Efficacy of Liposome-Encapsulated Oleanolic Acid against Liver Inflammation Induced by Fine Ambient Particulate Matter and Alcohol in Mice. | Pharmaceutics. 2022 May 23;14(5):1108. doi: 10.3390/pharmaceutics14051108. | 2022 |
| Bi-He Cai, Zhi-Yu Bai, Ching-Feng Lien, Si-Jie Yu, Rui-Yu Lu, Ming-Han Wu, Wei-Chen Wu, Chia-Chi Chen, Yi-Chiang Hsu. | NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner. | Biomolecules. 2022 Mar 12;12(3):438. doi: 10.3390/biom12030438. | 2022 |
| Fu Ou-Yang, Chung-Liang Li, Chia-Chi Chen, Yi-Chun Shen, Sin-Hua Moi, Chi-Wen Luo, Wei-Ya Xia, Ying-Nai Wang, Heng-Huan Lee, Lu-Hai Wang, Shao-Chun Wang. | De-glycosylated membrane PD-L1 in tumor tissues as a biomarker for responsiveness to atezolizumab (Tecentriq) in advanced breast cancer patients. | Am J Cancer Res. 2022 Jan 15;12(1):123-137. | 2022 |